Back to Search
Start Over
Analysis of Glycogen Synthase Kinase Inhibitors That Regulate Cytochrome P450 Expression in Primary Human Hepatocytes by Activation of β-Catenin, Aryl Hydrocarbon Receptor and Pregnane X Receptor Signaling
- Source :
- Toxicological Sciences, Toxicological Sciences, Oxford University Press (OUP), 2015, 148 (1), pp.261-275. ⟨10.1093/toxsci/kfv177⟩
- Publication Year :
- 2015
- Publisher :
- Oxford University Press (OUP), 2015.
-
Abstract
- SUPPLEMENTARY DATA are available online at http://toxsci.oxfordjournals.org/; International audience; Cytochrome P450 (CYP) expression and activity are not homogeneous in the liver lobules. Indeed, CYPs are mainly expressed and induced in centrilobular hepatocytes. The wingless-type MMTV integration site family (WNT)/β-catenin pathway was identified as a major regulator of this zonal organization. We have recently demonstrated that in primary human hepatocytes (PHHs), the expression of CYP2E1, CYP1A2, and aryl hydrocarbon receptor (AhR), but not of CYP3A4, is regulated by the WNT/β-catenin pathway in response to WNT3a, its canonical activator. Here, we investigated whether glycogen synthase kinase 3β (GSK3β) inhibitors, which mimic the action of WNT molecules, could be used in PHHs to activate the β-catenin pathway to study CYP expression. We assessed the activity of 6BIO (6-bromoindirubin-3'-oxime), CHIR99021 (6-((2-((4-(2,4-dichlorophenyl)-5-(4methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino) nicotinonitrile), and GSK3iXV (Pyridocarbazolo-cyclopentadienyl Ruthenium complex GSK3 inhibitor XV) that belong to structurally different families of GSK3β inhibitors. Using small interfering RNAs, reporter gene assays, and molecular docking predictions, we demonstrated that GSK3β inhibitors can activate the WNT/β-catenin pathway in PHHs to regulate CYP2E1 expression. We also found that 6BIO and GSK3iXV are AhR full agonists that participate, through AhR signaling, to CYP1A2 induction. Conversely, CHIR99021 is an AhR partial agonist, and a pregnane X receptor ligand and partial agonist, thus regulating CYP1A2 and CYP3A4 gene expression in a β-catenin-independent manner. In conclusion, GSK3β inhibitors can activate the WNT/β-catenin pathway in PHHs. Nevertheless, their role in CYP regulation should be analyzed with caution as these molecules can interact with xenosensors.
- Subjects :
- Male
Receptors, Steroid
Indoles
Beta-catenin
Pyridines
Recombinant Fusion Proteins
PXR
[SDV]Life Sciences [q-bio]
Toxicology
Glycogen Synthase Kinase 3
Cytochrome P-450 Enzyme System
Genes, Reporter
GSK-3
Cell Line, Tumor
CYP
Oximes
Gene expression
Basic Helix-Loop-Helix Transcription Factors
Organometallic Compounds
Humans
CTNNB1
Protein Kinase Inhibitors
Wnt Signaling Pathway
Cells, Cultured
beta Catenin
Cytochrome P-450 Enzyme Inducers
Pregnane X receptor
Glycogen Synthase Kinase 3 beta
biology
AhR
Pregnane X Receptor
Wnt signaling pathway
GSK3β
Aryl hydrocarbon receptor
Molecular biology
Molecular Docking Simulation
Pyrimidines
Receptors, Aryl Hydrocarbon
crosstalk
Enzyme Induction
Catenin
Hepatocytes
biology.protein
Female
RNA Interference
Signal transduction
Subjects
Details
- ISSN :
- 10960929, 10966080, and 10966099
- Volume :
- 148
- Database :
- OpenAIRE
- Journal :
- Toxicological Sciences
- Accession number :
- edsair.doi.dedup.....787fe5c915e4b758c6f6dc2740414160
- Full Text :
- https://doi.org/10.1093/toxsci/kfv177